Related Experiment Videos
5-fluorouracil (5-FU) plus high dose folinic acid (FA): a modified scheme with reduced toxicity
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Treatment of Cutaneous T-cell Lymphoma with Cyclosporin A: Case Report and Literature Review.
Leukemia & lymphoma·2016
Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.
Journal of breath research·2012
Decline of exhaled isoprene in lung cancer patients correlates with immune activation.
Journal of breath research·2012
In-medium isovector piN amplitude from low-energy pion scattering.
Physical review letters·2004
A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands)·2001
Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers.
International journal of oncology·2001
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026